POTS Symptoms: Why They Don't Match Your Autonomic Test Results

If you have POTS or another form of dysautonomia, at some point you have probably filled out a symptom questionnaire. Maybe it was the COMPASS-31, maybe a survey your neurologist handed you, maybe an intake form for a telehealth clinic that promised to sort you out. You rated your dizziness, your palpitations, your brain fog, your gut, all of it, on a scale. And somewhere in the back of your mind, you assumed the worse you scored, the more clearly the testing that came next would show what was wrong.

A study published in 2024 took that assumption apart. Researchers at Brigham and Women's Faulkner Hospital compared how 2,627 patients rated their own autonomic symptoms against what objective testing measured in those same people. The two did not line up, and the gap was not small.

What the Study Compared: Symptom Surveys vs Autonomic Testing

The researchers pulled two kinds of data from every patient. On one side, the subjective side, they used validated symptom questionnaires: the Survey of Autonomic Symptoms and the COMPASS-31, the same self-report tools used in autonomic clinics everywhere. On the other side, the objective side, they used standardized autonomic testing: the Valsalva maneuver, deep breathing, a sudomotor sweat test, and a tilt test, graded on two established severity scales.

Then they asked a simple question. In the same patient, does the symptom score predict the test result?

The internal numbers were reassuring. The two questionnaires agreed strongly with each other (a correlation of 0.74). The two objective grading scales agreed strongly with each other as well (0.81). Each set of tools was reliable on its own terms. The problem showed up when they compared across the divide: between the symptom scores and the objective testing, there was no correlation at all. That held no matter which diagnosis the patients carried, including POTS, ME/CFS, long COVID, and hypermobile EDS.

That is a strange result if you assume a symptom is a readout of the underlying problem. It stops being strange once you separate two things that usually get treated as one: how a nervous system problem feels, and how much measurable dysfunction it has actually produced.

What the Mismatch Means (Your Symptoms Aren't Fake)

It would be easy to read that study the wrong way, so let us be clear about what it does not say. It does not say patients are unreliable narrators of their own bodies. It does not hand any doctor permission to wave off your experience because a test looked tidy. If anything, it says the opposite, because the mismatch ran in both directions.

Some patients rated their symptoms as severe while their objective testing showed a milder measurable deficit. Others rated their symptoms as mild while their testing showed significant dysfunction. Neither group was wrong about how they felt. Both were telling the truth. The felt intensity of a problem and the measured size of it are simply two different axes, and knowing one does not let you predict the other.

That second group is the one that keeps us up at night. If your evaluation is driven only by how loudly the symptoms present, a quiet-but-real problem gets missed. It cuts the other way too. Plenty of people arrive with what looks like an orthostatic complaint, standing makes them feel awful, and the reflex is to chase blood pressure. Measure it properly and the driver turns out to be a vestibular or visual problem, not a blood pressure one. The symptom pointed in a direction. Only the measurement told us whether that direction was right.

Why Questionnaire-Only Diagnosis Falls Short

Here is the part that makes this more than an academic curiosity. There are not enough clinicians trained to run and interpret full autonomic testing, and there are a lot of people who need it. To bridge that shortage, the field is drifting toward questionnaire-first, telehealth-first evaluation: fill out a survey, hop on a call, get sorted onto a medication algorithm. It is faster, it is cheaper, and it scales.

It is also the exact substitution this study says you cannot make. When the authors compared thousands of patients, the questionnaires could not stand in for the testing. Their conclusion was blunt: autonomic questionnaires cannot be recommended as a replacement for autonomic testing. That matters whether you are a patient trying to get an accurate diagnosis or a clinician trying to treat one.

The way we think about it is straightforward. Your symptoms are how you tell us where it hurts. That is valuable, and it is where every evaluation should start. But a symptom is a pointer, not a measurement. It tells us where to look. It does not tell us what is actually broken, and it certainly does not tell us which treatment is the right one. When someone goes straight from how you feel to a prescription, they have skipped the step in the middle that is supposed to decide the prescription.

What Comprehensive Autonomic Testing Actually Measures

If a symptom score cannot stand in for testing, the obvious next question is what testing should include. The battery in this study measured cardiovascular reflexes, sweat response, and small fiber nerve function, which is a real step up from heart rate alone. Our team would push it one step further, and it is the step that ties all of this back to your brain.

Most of the symptoms that bring people in, the dizziness, the fog, the sense of the lights dimming when you stand, are downstream of one thing: whether your brain is getting enough blood flow. A tilt test that logs only heart rate and blood pressure cannot see that. It is watching the pump and ignoring what reaches the destination. Add a real-time measure of blood flow to the brain, using transcranial Doppler, along with a measure of carbon dioxide in your breath, and the same tilt test starts telling you why the symptoms happen instead of just confirming that they do.

This is not a fringe idea. In earlier work, the same lead author showed that when you track cerebral blood flow during a tilt test, distinct patterns emerge across the common orthostatic syndromes, patterns that heart rate and blood pressure alone flatten into a single confusing picture. That is the whole argument for testing that goes beyond the tilt table: the measurement you add determines the answer you can get.

What to Ask For in a POTS or Dysautonomia Workup

The useful thing to walk away with is small and specific. A symptom questionnaire, however high or low your score, is not a measurement of the problem underneath it. It is a starting point for the conversation, not a substitute for the workup. If you are being evaluated for POTS or dysautonomia, it is fair to ask whether the plan includes objective autonomic testing, and whether that testing measures blood flow to your brain, not only your heart rate and blood pressure.

And if someone offers to diagnose and treat your dysautonomia from a questionnaire and a video call alone, this study is a good reason to slow down and ask what they plan to measure. You have spent enough time being sorted by how things look on paper. The point of testing is to find the mechanism that the paper keeps missing, so that treatment finally has something real to aim at.

← Back to Blog